PubMed Health⌕ Search

PubMed · 12157911

When does a cohort's mortality differ from what we might expect?

Abstract

The authors have developed a model to systematically analyze a matrix of mortality data. "Through its detailed description of the structure of the matrix, it offers the possibility of confirming certain hypotheses or of formulating new ones about the mortality experience of certain peculiar cohorts. The descriptive power of the method will be seen here in application to the French mortality experience over the period 1899-1981." This is a revised version of a paper originally presented at the 1988 Annual Meeting of the Population Association of America.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Wilmoth, J Vallin, G Caselli. 1990. When does a cohort's mortality differ from what we might expect?. https://pubmed.ncbi.nlm.nih.gov/12157911/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies.

OBJECTIVES: It remains debated whether patients with ulcerative colitis (UC) are at greater risk of dying and whether a possible alteration in mortality can be attributed to specific causes of death. We aimed to clarify this issue by conducting a meta-analysis of population-based inception cohort studies on overall and cause-specific mortality in patients with UC. METHODS: The MEDLINE search engine and abstracts from international conferences were searched for relevant literature by use of explicit search criteria. STATA meta-analysis software was used to calculate pooled risk estimates (SMR, standardized mortality ratio, observed/expected deaths) of overall mortality and specific causes of death and to conduct metaregression analyses of the influence of specific variables on SMR. RESULTS: Ten papers fulfilled the inclusion criteria, reporting SMRs varying from 0.7 to 1.4. The overall pooled estimate was 1.1 (95% confidence interval [CI] 0.9-1.2, P= 0.42). However, greater risk of dying was observed during the first years of follow-up, in patients with extensive colitis, and in patients from Scandinavia. Metaregression analysis showed an increase in SMR by increasing cohort size. UC-related mortality accounted for 17% of all deaths. Mortality from gastrointestinal diseases, nonalcoholic liver diseases, pulmonary embolisms, and respiratory diseases was increased whereas mortality from pulmonary cancer was reduced. CONCLUSIONS: The overall risk of dying in patients with UC did not differ from that of the background population, although subgroups of patients were at greater risk of dying. The cause-of-death distribution seemed to differ from that of the background population.

Cause of Death↗